Drug Profile
MT 303
Alternative Names: Glyceollin microbiome modulator - MicroBiome Therapeutics; MT-303Latest Information Update: 23 Aug 2023
Price :
$50
*
At a glance
- Originator MicroBiome Therapeutics
- Class Benzofurans; Isoflavones; Small molecules
- Mechanism of Action Fatty acid inhibitors; Lipid inhibitors; Microbiome modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Obesity
Most Recent Events
- 23 Aug 2023 Discontinued - Preclinical for Obesity in USA (unspecified route)
- 28 Apr 2019 No recent reports of development identified for preclinical development in Obesity in USA
- 01 Mar 2015 Preclinical trials in Obesity in USA (unspecified route) before March 2015